The Department of Health and Human Services posted its presentation from the June Medicaid Pharmacy Liaison Committee meeting. Note that the deck contains timely information concerning how pharmacies can enroll to be reimbursed for clinical services. 

Also in Michigan, the agenda for the June 17 Board of Pharmacy meeting has been released. 

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

The Department of Health and Human Services released Bulletin MMP 26-20 announcing that Medicaid and other public programs will reimburse pharmacists for immunizations, lab testing, antiviral treatments and counseling and prescribing of hormonal contraceptives, effective July 1, contingent upon CMS approval. It also outlines the provider enrollment process.

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

The Department of Health and Human Services (MDHHS) is soliciting comments from the public on the Medicaid Health Plan Common Formulary, which applies to managed care organization (MCO) claims. The public may submit comments by June 12 on the drugs included or not included on the Common Formulary, new drug products, prior authorization criteria, step therapy criteria and other topics related to drug coverage under the Common Formulary.

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

The Final Rule for expanded pharmacists' immunization, testing and contraceptive prescribing authority has been approved and will become final when approved by the Secretary of State. In response, Medicaid published Provider Letter L 26-09 on February 12, 2026, that includes: 

• Notice of Intent to Submit a State Plan Amendment and Alternative Benefit Plan State Plan Amendment to Clarify Pharmacist Services Authorization 

• Policy promulgation to clarify pharmacist enrollment and coverage of expanded scope of practices services coverage.  

For more detail, including a PowerPoint presentation, visit the Pharmacy Liaison Committee page.

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

The Board of Pharmacy posted agendas for the March 2 full Board and Disciplinary Subcommittee meetings.

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

Medicaid issued Bulletin MMP 26-02 on January 23 that updates the Fee-for-Service Prior Authorization Process, excluding drug claims. 

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

The public is invited to attend the Medicaid Health Plan Common Formulary stakeholder meeting from 9:30 am to 12:00 noon on October 20. It will be held virtually via Zoom using the password SLVU14. Participants may also access the meeting by phone by dialing 408-961-3928 and entering access code 351013. Attendees are asked to RSVP by emailing KrepsD@michigan.gov by October 15. 

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

Medicaid has issued bulletin MMP 25-44, removing the pharmacy copayment for drugs used to prevent Human Immunodeficiency Virus (HIV) (Pre-Exposure Prophylaxis [PrEP] & Post-Exposure Prophylaxis [PEP]).

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

The Department of Health and Human Services has proposed policy change 2534-Pharmacy, removing copays for PrEP & PEP, effective November 2, 2025, contingent upon CMS approval. Comments are due by September 15 to GoethalsV@michigan.gov.

For more information, contact NACDS’ Jill McCormack at 717-592-8977.